LMP7 inhibitor(Shouyao)

N/A

Report date: 2025/11/06 15:39:34
NME

Base Information

Drug NameLMP7 inhibitor(Shouyao)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionProteasome subunit beta type-8 inhibitors
TargetsProteasome subunit beta type-8
Therapy Area/IndicationsMultiple MyelomaLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesShouyao Holding (Beijing) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShouyao Holding (Beijing) Co Ltd
Inactive CompaniesN/A
Active IndicationsMultiple MyelomaLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A